Point72 Middle East FZE »

Akoya Biosciences shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Akoya Biosciences (AKYA) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Akoya Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Akoya Biosciences held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akoya Biosciences by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $31k 6.4k 4.88

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Akoya Biosciences

Blue Water Life Science Advisors
Vanguard Group
Board of Trustees of The Leland Stanford Junior University
Bp Wealth Management
Peddock Capital Advisors
Charles Schwab Investment Management
Millennium Management
Schonfeld Strategic Advisors
Osterweis Capital Management
Kent Lake Capital
Squarepoint Ops
Bank of New York Mellon
ZWJ Investment Counsel
Barclays
Rhumbline Advisers

View all funds holding Akoya Biosciences